- Home
- CMTL vs BRNS Comparison
CMTL vs BRNS Comparison
Compare CMTL & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMTL
- BRNS
- Stock Information
- Founded
- CMTL 1967
- BRNS 2016
- Country
- CMTL United States
- BRNS United Kingdom
- Employees
- CMTL N/A
- BRNS N/A
- Industry
- CMTL Radio And Television Broadcasting And Communications Equipment
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- CMTL Technology
- BRNS Health Care
- Exchange
- CMTL Nasdaq
- BRNS Nasdaq
- Market Cap
- CMTL 41.7M
- BRNS 28.2M
- IPO Year
- CMTL N/A
- BRNS 2021
- Fundamental
- Price
- CMTL $1.48
- BRNS $0.90
- Analyst Decision
- CMTL Strong Buy
- BRNS Strong Buy
- Analyst Count
- CMTL 1
- BRNS 2
- Target Price
- CMTL $9.25
- BRNS $3.00
- AVG Volume (30 Days)
- CMTL 144.5K
- BRNS 33.8K
- Earning Date
- CMTL 06-17-2025
- BRNS 05-07-2025
- Dividend Yield
- CMTL N/A
- BRNS N/A
- EPS Growth
- CMTL N/A
- BRNS N/A
- EPS
- CMTL N/A
- BRNS N/A
- Revenue
- CMTL $496,641,000.00
- BRNS $14,969,000.00
- Revenue This Year
- CMTL N/A
- BRNS N/A
- Revenue Next Year
- CMTL $4.14
- BRNS N/A
- P/E Ratio
- CMTL N/A
- BRNS N/A
- Revenue Growth
- CMTL N/A
- BRNS 4381.74
- 52 Week Low
- CMTL $1.19
- BRNS $0.64
- 52 Week High
- CMTL $5.16
- BRNS $2.45
- Technical
- Relative Strength Index (RSI)
- CMTL 50.26
- BRNS 50.44
- Support Level
- CMTL $1.36
- BRNS $0.87
- Resistance Level
- CMTL $1.55
- BRNS $1.02
- Average True Range (ATR)
- CMTL 0.10
- BRNS 0.12
- MACD
- CMTL 0.03
- BRNS 0.02
- Stochastic Oscillator
- CMTL 80.56
- BRNS 45.24
About CMTL Comtech Telecommunications Corp.
Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.